Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/00033197221094450 | DOI Listing |
JACC Adv
December 2024
Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
Background: Valvular heart disease (VHD) management has evolved rapidly in recent decades, but disparities in health care access persist among countries with varying socioeconomic backgrounds.
Objectives: The purpose of this study was to investigate global mortality trends from VHD and assess the difference between middle- and high-income countries.
Methods: We obtained mortality data from the World Health Organization Mortality Database for VHD and its subgroups (rheumatic valvular disease [RVD], infective endocarditis [IE], aortic stenosis [AS], and mitral regurgitation [MR]) from 2000 to 2019.
J Cardiothorac Vasc Anesth
November 2024
The Ohio State University Wexner Medical Center, Columbus, Ohio.
Arch Cardiovasc Dis
November 2024
Inserm U1011-EGID, CHU de Lille, Institut Pasteur de Lille, université de Lille, 59000 Lille, France; Centre de simulation en santé PRESAGE, faculté de médecine, université de Lille, 59045 Lille, France.
Asian J Surg
November 2024
Department of Cardiovascular Medicine, Chengdu Fifth People's Hospital, Wenjiang, 610000, Chengdu, Sichuan, China. Electronic address:
Am J Cardiovasc Drugs
November 2024
München Klinik Neuperlach, Department of Cardiology, Academic Teaching Hospital of LMU University of Munich, Oskar-Maria-Graf-Ring 51, 81737, München, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!